Form 4 for DGX Quest Diagnostics
Accepted 2021-07-28 00:00:00 ET · period of report 2021-07-26 · accession 0001022079-21-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-28 | 2021-07-26+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | M - OptEx | $95.80 | +38.6K | 317.2K | +14% | +$3.70M |
| DM | 2021-07-28 | 2021-07-26+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | S - Sale+OE | $140.01 | -38.6K | 284.4K | -12% | -$5.40M |
| DM | 2021-07-28 | 2021-07-26+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | M - OptEx | $95.80 | -38.6K | 149.2K | -21% | -$3.70M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-26 | M | A | 5,813 | $95.80 | 290,240 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-27 | S | D | 32,788 | $140.01 | 284,427 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $140.00 to $140.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-07-27 | M | A | 32,788 | $95.80 | 317,215 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-26 | S | D | 5,813 | $140.03 | 284,427 | D | — | — | |
| 5 | Derivative | Non-Qualifed Stock Option (right to buy) | 2021-07-26 | M | D | 5,813 | $95.80 | 182,032 | D | $95.80 · — to 2027-02-21 | 5,813 Common Stock | (F3) The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. |
| 6 | Derivative | Non-Qualifed Stock Option (right to buy) | 2021-07-27 | M | D | 32,788 | $95.80 | 149,244 | D | $95.80 · — to 2027-02-21 | 32,788 Common Stock | (F3) The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. |